Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Six-week Hydrogen Plus Pyrroloquinoline Quinone (PQQ) Intake on Mitochondrial Biomarkers, Brain Metabolism and Cognition in the Elderly With Mild Cognitive Impairment

NCT05910047 is registered in ClinicalTrials.gov with University of Novi Sad, Faculty of Sport and Physical Education as lead sponsor.

NCT NCT05910047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05910047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Six-week Hydrogen Plus Pyrroloquinoline Quinone (PQQ) Intake on Mitochondrial Biomarkers, Brain Metabolism and Cognition in the Elderly With Mild Cognitive Impairment
Lead sponsor
University of Novi Sad, Faculty of Sport and Physical Education
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2023
Completion date
March 31, 2024
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-associated memory impairment